Literature DB >> 19601718

Drug metabolism and pharmacokinetics.

Margherita Strolin Benedetti1, Rhys Whomsley, Italo Poggesi, Willi Cawello, François-Xavier Mathy, Marie-Laure Delporte, Peggy Papeleu, Jean-Baptiste Watelet.   

Abstract

In this article, aspects of absorption, distribution, metabolism, and excretion have been described bearing in mind the pathogenesis of allergic diseases and their possible therapeutic opportunities. The importance of the routes of administration of the different therapeutic groups has been emphasized. The classical aspects of drug metabolism and disposition related to oral administration have been reviewed, but special emphasis has been given to intranasal, cutaneous, transdermal, and ocular administration as well as to the absorption and the subsequent bioavailability of drugs. Drug-metabolizing enzymes and transporters present in extrahepatic tissues, such as nasal mucosa and the respiratory tract, have been particularly discussed. As marketed antiallergic drugs include both racemates and enantiomers, aspects of stereoselective absorption, distribution, metabolism, and excretion have been discussed. Finally, a new and promising methodology, microdosing, has been presented, although it has not yet been applied to drugs used in the treatment of allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601718     DOI: 10.1080/10837450902891295

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  12 in total

Review 1.  A comprehensive insight on ocular pharmacokinetics.

Authors:  Vibhuti Agrahari; Abhirup Mandal; Vivek Agrahari; Hoang M Trinh; Mary Joseph; Animikh Ray; Hicheme Hadji; Ranjana Mitra; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  Minimization of CYP2D6 Polymorphic Differences and Improved Bioavailability via Transdermal Administration: Latrepirdine Example.

Authors:  Marci L Chew; Joyce Mordenti; Thean Yeoh; Gautam Ranade; Ruolun Qiu; Juanzhi Fang; Yali Liang; Brian Corrigan
Journal:  Pharm Res       Date:  2016-04-12       Impact factor: 4.200

3.  Clinical pharmacokinetic study of latrepirdine via in silico sublingual administration.

Authors:  Joana Santos; Luísa Lobato; Nuno Vale
Journal:  In Silico Pharmacol       Date:  2021-04-05

4.  Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug.

Authors:  Dong Ki Kim; Jay Wook Lee; Kwang-Hee Shin; Sejoong Kim; Kook-Hwan Oh; Myounghee Kim; Kyung-Sang Yu; Jung Pyo Lee; Chun-Soo Lim; Yon Su Kim; Kwon Wook Joo
Journal:  BMC Nephrol       Date:  2014-03-17       Impact factor: 2.388

5.  Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites.

Authors:  Margarida L F Martins; Paniz Heydari; Wenlong Li; Alejandra Martínez-Chávez; Nikkie Venekamp; Maria C Lebre; Luc Lucas; Jos H Beijnen; Alfred H Schinkel
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

6.  Metabolism of Long-Acting Rilpivirine After Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076).

Authors:  Herana Kamal Seneviratne; Joseph Tillotson; Julie M Lade; Linda-Gail Bekker; Sue Li; Subash Pathak; Jessica Justman; Nyaradzo Mgodi; Shobha Swaminathan; Nirupama Sista; Jennifer Farrior; Paul Richardson; Craig W Hendrix; Namandje N Bumpus
Journal:  AIDS Res Hum Retroviruses       Date:  2021-01-13       Impact factor: 2.205

Review 7.  Achievements in Thermosensitive Gelling Systems for Rectal Administration.

Authors:  Maria Bialik; Marzena Kuras; Marcin Sobczak; Ewa Oledzka
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

8.  In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics.

Authors:  Sin-Eun Kim; Hyung-Ju Seo; Yeojin Jeong; Gyung-Min Lee; Seung-Bae Ji; So-Young Park; Zhexue Wu; Sangkyu Lee; Sunghwan Kim; Kwang-Hyeon Liu
Journal:  Pharmaceutics       Date:  2021-06-23       Impact factor: 6.321

9.  Targeted Drug and Metabolite Imaging: Desorption Electrospray Ionization Combined with Triple Quadrupole Mass Spectrometry.

Authors:  Lieke Lamont; Gert B Eijkel; Emrys A Jones; Bryn Flinders; Shane R Ellis; Tiffany Porta Siegel; Ron M A Heeren; Rob J Vreeken
Journal:  Anal Chem       Date:  2018-11-06       Impact factor: 6.986

10.  Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme.

Authors:  Dimitrios Vagiannis; Eva Novotna; Adam Skarka; Sarah Kammerer; Jan-Heiner Küpper; Si Chen; Lei Guo; Frantisek Staud; Jakub Hofman
Journal:  Cancers (Basel)       Date:  2020-03-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.